North American Neuromodulation Market Outlook and Strategic Insights by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

North American Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology [External (Non-Invasive) Neuromodulation and Internal Neuromodulation], Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine), and End User (Hospitals, Clinics, and Home Healthcare) and Country

Report Date : Nov 2020
Report Code : TIPRE00016293

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 108

Page Updated: Oct 2024

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Neuromodulation market in North America is expected to grow from US$ 3,029.72 million in 2019 to US$ 6,612.00 Million by 2027. This represents a CAGR of 10.6% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to increasing incidence of neurological disorders, growing developments in neuromodulation technology are projected to drive the North America neuromodulation market during the forecast period.

The US has observed fast growth in the neuromodulation market within the past few years and is expected to lead the market in North America during the forecast period. Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation

US Neuromodulation Market Revenue and Forecast to 2027 (US$ Million)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA NEUROMODULATION – MARKET SEGMENTATION

By Technology

External (Non-Invasive) Neuromodulation
- Respiratory Electrical Stimulation
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
Internal Neuromodulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation

By Application

Chronic Pain Management
Failed Back Syndrome
Epilepsy
Tremor
Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Obsessive-Compulsive Disorder
Migraine

By End User

Hospitals
Clinics
Home Healthcare

By Country

US
Canada
Mexico

Company Profiles

Abbott
Boston Scientific Corporation
Medtronic
NeuroPace, Inc.
NeuroSigma, Inc.
NEVRO CORP.
Synapse Biomedical Inc.
Soterix Medical Inc
Integer Holdings Corporation
Magstim

North American Neuromodulation Report Scope

Report Attribute	Details
Market size in 2019	US$ 3,029.72 Million
Market Size by 2027	US$ 6,612.00 Million
Global CAGR (2020 - 2027)	10.6%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Technology External Neuromodulation Internal Neuromodulation By Application Chronic Pain Management Failed Back Syndrome Epilepsy Tremor Incontinence Depression Dystonia Gastroparesis Parkinson's Disease Obsessive-Compulsive Disorder Migraine By End User Hospitals Clinics Home Healthcare
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Abbott Boston Scientific Corporation Medtronic NeuroPace, Inc. NeuroSigma, Inc. NEVRO CORP. Synapse Biomedical Inc. Soterix Medical Inc Integer Holdings Corporation

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North American Neuromodulation Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy